GM, S., KL, R., S, H., MD, W., CL, D., C, A., . . . RC, A. (2026). Mapping the secondary response to traumatic brain injury using spatial transcriptomics shows acute 4-aminopyridine treatment mitigates axonal and molecular pathology. Acta neuropathologica communications, 14(1), 36. https://doi.org/10.1186/s40478-025-02219-1
Chicago Style (17th ed.) CitationGM, Sullivan, Radomski KL, He S, Wilkerson MD, Dalgard CL, Alba C, Zi X, Doughty ML, and Armstrong RC. "Mapping the Secondary Response to Traumatic Brain Injury Using Spatial Transcriptomics Shows Acute 4-aminopyridine Treatment Mitigates Axonal and Molecular Pathology." Acta Neuropathologica Communications 14, no. 1 (2026): 36. https://doi.org/10.1186/s40478-025-02219-1.
MLA (9th ed.) CitationGM, Sullivan, et al. "Mapping the Secondary Response to Traumatic Brain Injury Using Spatial Transcriptomics Shows Acute 4-aminopyridine Treatment Mitigates Axonal and Molecular Pathology." Acta Neuropathologica Communications, vol. 14, no. 1, 2026, p. 36, https://doi.org/10.1186/s40478-025-02219-1.